A Study to Evaluate Inetetamab + Pyrotinib + Chemotherapy in Previously Untreated HER2-Positive Metastatic Breast Cancer
Clinical trial NCT05621434 · UNKNOWN
Trial details
- NCT number
- NCT05621434
- Sponsor
- Fujian Medical University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-10
- Primary completion
- 2024-12-10
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.